Introduction:Basic information about CAS 163253-35-8|Sitafloxacin hydrate, including its chemical name, molecular formula, synonyms, physicochemical properties, and safety information, etc.
| Common Name | Sitafloxacin hydrate |
|---|
| CAS Number | 163253-35-8 | Molecular Weight | 436.84 |
|---|
| Density | / | Boiling Point | 629.2ºC at 760mmHg |
|---|
| Molecular Formula | C19H18ClF2N3O3.3/2H2O | Melting Point | 145-147°C (dec.) |
|---|
| MSDS | / | Flash Point | 334.3ºC |
|---|
Names
| Name | Sitafloxacin Sesquihydrate |
|---|
| Synonym | More Synonyms |
|---|
Sitafloxacin hydrate BiologicalActivity
| Description | Sitafloxacin Hydrate is a new-generation, broad-spectrum oral fluoroquinolone antibiotic.Target: AntibacterialSitafloxacin Hydrate, a new-generation, broad-spectrum oral fluoroquinolone that is very active against many Gram-positive, Gram-negative and anaerobic clinical isolates, including strains resistant to other fluoroquinolones, was recently approved in Japan for the treatment of respiratory and urinary tract infections [1]. In terms of clinical efficacy, oral sitafloxacin was noninferior to oral levofloxacin in the treatment of community-acquired pneumonia or an infectious exacerbation of chronic respiratory tract disease, noninferior to oral tosufloxacin in the treatment of community-acquired pneumonia, and noninferior to oral levofloxacin in the treatment of complicated urinary tract infections, according to the results of randomized, double-blind, multicentre, noninferiority trials. Noncomparative studies demonstrated the efficacy of oral sitafloxacin in otorhinolaryngological infections, urethritis in men, C. trachomatis-associated cervicitis in women and odontogenic infections [2]. |
|---|
| Related Catalog | Signaling Pathways >>Anti-infection >>BacterialResearch Areas >>Infection |
|---|
| References | [1]. Anderson, D.L., Sitafloxacin hydrate for bacterial infections. Drugs Today (Barc), 2008. 44(7): p. 489-501. [2]. Keating, G.M., Sitafloxacin: in bacterial infections. Drugs, 2011. 71(6): p. 731-44. |
|---|
Chemical & Physical Properties
| Boiling Point | 629.2ºC at 760mmHg |
|---|
| Melting Point | 145-147°C (dec.) |
|---|
| Molecular Formula | C19H18ClF2N3O3.3/2H2O |
|---|
| Molecular Weight | 436.84 |
|---|
| Flash Point | 334.3ºC |
|---|
| PSA | 97.79000 |
|---|
| LogP | 3.40360 |
|---|
| Vapour Pressure | 1.06E-16mmHg at 25°C |
|---|
| InChIKey | MPORYQCGWFQFLA-ONPDANIMSA-N |
|---|
| SMILES | NC1CN(c2c(F)cc3c(=O)c(C(=O)O)cn(C4CC4F)c3c2Cl)CC12CC2.NC1CN(c2c(F)cc3c(=O)c(C(=O)O)cn(C4CC4F)c3c2Cl)CC12CC2.O.O.O |
|---|
| Storage condition | Hygroscopic, -20°C Freezer, Under Inert Atmosphere |
|---|
Synonyms
| Sitafloxacin hydrate |
| 7-[(7S)-7-Amino-5-azaspiro[2.4]hept-5-yl]-8-chloro-6-fluoro-1-[(1R,2S)-2-fluorocyclopropyl]-4-oxo-1,4-dihydro-3-quinolinecarboxylic acid hydrate (1:1) |
| DU 6859A,DU 6859,DU-6859 |
| 3-Quinolinecarboxylic acid, 7-[(7S)-7-amino-5-azaspiro[2.4]hept-5-yl]-8-chloro-6-fluoro-1-[(1R,2S)-2-fluorocyclopropyl]-1,4-dihydro-4-oxo-, hydrate (1:1) |
| Sitafloxacin |
| Sitafloxacin (hydrate) |